Literature DB >> 9427694

Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment.

S Ogilvy1, A G Elefanty, J Visvader, M L Bath, A W Harris, J M Adams.   

Abstract

The vav gene is expressed in all hematopoietic but few other cell types. To explore its unusual compartment-wide regulation, we cloned the murine gene, sequenced its promoter region, identified DNase I hypersensitive (HS) sites in the chromatin, and tested their promoter activity with a beta-galactosidase (beta-gal) reporter gene in cell lines and transgenic mice. Whereas fibroblasts had no HS sites, a myeloid and an erythroid cell line contained five, located 0.2 kb (HS1), 1.9 kb (HS2), and 3.6 kb (HS3) upstream from the transcription start and 0.6 kb (HS4) and 10 kb (HS5) downstream. A vav DNA fragment including HS1 promoted beta-gal expression in a myeloid but not a fibroblast line. Expression in leukocytes of transgenic mice also required HS2 and HS5. Only hematopoietic organs contained beta-gal, but virtually all beta-gal+ cells were B or T lymphocytes. Expression was always variegated (mosaic), and the proportion of beta-gal+ cells declined with lymphoid maturation and animal age. Thus, these vav regulatory elements promoted hematopoietic-specific expression in vivo, at least in lymphocytes, but the transgene was sporadically silenced. Maintaining pan-hematopoietic expression may require additional vav elements or an alternative reporter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427694

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.

Authors:  Evangelia Loizou; Ana Banito; Geulah Livshits; Yu-Jui Ho; Richard P Koche; Francisco J Sánchez-Rivera; Allison Mayle; Chi-Chao Chen; Savvas Kinalis; Frederik O Bagger; Edward R Kastenhuber; Benjamin H Durham; Scott W Lowe
Journal:  Cancer Discov       Date:  2019-05-08       Impact factor: 39.397

2.  Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia.

Authors:  S L Masters; K R Palmer; W S Stevenson; D Metcalf; E M Viney; N S Sprigg; W S Alexander; N A Nicola; S E Nicholson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.

Authors:  S Ogilvy; R Ferreira; S G Piltz; J M Bowen; B Göttgens; A R Green
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

4.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

Authors:  S E Nicholson; D De Souza; L J Fabri; J Corbin; T A Willson; J G Zhang; A Silva; M Asimakis; A Farley; A D Nash; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Matthew Deater; Kathryn Schubert; Laura Marquez-Loza; Carl Pelz; David A Sinclair; Markus Grompe
Journal:  Stem Cell Res       Date:  2015-05-22       Impact factor: 2.020

6.  KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.

Authors:  Yue Wei; Hong Zheng; Naran Bao; Shan Jiang; Carlos E Bueso-Ramos; Joseph Khoury; Caleb Class; Yue Lu; Kevin Lin; Hui Yang; Irene Ganan-Gomez; Daniel T Starczynowski; Kim-Anh Do; Simona Colla; Guillermo Garcia-Manero
Journal:  Blood Adv       Date:  2018-10-09

7.  NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

Authors:  Ying-Wei Lin; Christopher Slape; Zhenhua Zhang; Peter D Aplan
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

8.  Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.

Authors:  Ningfei An; Ying-Wei Lin; Sandeep Mahajan; Joshua N Kellner; Yong Wang; Zihai Li; Andrew S Kraft; Yubin Kang
Journal:  Stem Cells       Date:  2013-06       Impact factor: 6.277

9.  Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation.

Authors:  Anjali Mishra; Shujun Liu; Gregory H Sams; Douglas P Curphey; Ramasamy Santhanam; Laura J Rush; Deanna Schaefer; Lauren G Falkenberg; Laura Sullivan; Laura Jaroncyk; Xiaojuan Yang; Harold Fisk; Lai-Chu Wu; Christopher Hickey; Jason C Chandler; Yue-Zhong Wu; Nyla A Heerema; Kenneth K Chan; Danilo Perrotti; Jianying Zhang; Pierluigi Porcu; Frederick K Racke; Ramiro Garzon; Robert J Lee; Guido Marcucci; Michael A Caligiuri
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

10.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.

Authors:  S E Nicholson; T A Willson; A Farley; R Starr; J G Zhang; M Baca; W S Alexander; D Metcalf; D J Hilton; N A Nicola
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.